ArticleBMC cardiovascular disorders2025
Predictive value of clinical syntax score for clinical outcomes on patients with acute coronary syndrome undergoing rotational atherectomy.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThis study aimed to investigate whether clinical syntax score (CSS) could predict in-hospital and long-term outcomes in patients with acute coronary syndrome (ACS) who underwent drug-eluting stent implantation following rotational atherectomy (RA).
methodsA total of 179 patients with ACS who underwent drug-eluting stent implantation following RA were recruited. Angiographic parameters, age, creatinine, and left ventricular ejection fraction were used to calculate CSS in the enrolled patients. The patients were classified into low-CSS (n = 89) and high-CSS (n = 90) groups. Major adverse cardiac event (MACE) was defined as cardiac death, recurrent myocardial infarction, target vessel revascularization (TVR), and ischemic stroke. The predictive value of CSS for in-hospital and long-term outcomes was evaluated by the multivariable logistic and Cox analyses.
resultsAngiographic success was 97.8% in patients with ACS who underwent drug-eluting stent implantation following RA. In-hospital MACE was significantly higher in the high-CSS group than in the low-CSS group (21.11% vs. 6.74%), however, CSS was not independently associated with in-hospital MACE after multivariable adjustment. The Kaplan–Meier analysis revealed a significantly higher occurrence of all-cause death and MACE in the high-CSS group. The multivariate analysis showed that CSS was an independent predictor of MACE, cardiac death, and TVR at a mean follow-up of 3 years in patients with ACS who underwent RA.
conclusionsCSS was not independently associated with in-hospital MACE. On the contrary, the CSS has predictive value for long-term major adverse cardiovascular events (MACE) in patients with acute coronary syndrome (ACS) following drug-eluting stent implantation. However, this finding still requires further validation through large-scale studies with long-term follow-up in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.